Co-Diagnostics, Inc. Earnings Per Share (Diluted)
Co-Diagnostics, Inc. (CODX) reported Earnings Per Share (Diluted) of -$1.46 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-13
- Co-Diagnostics, Inc. earnings per share, diluted for the quarter ending 2026-06-30 was -$1.46.
- Co-Diagnostics, Inc. earnings per share, diluted for the quarter ending 2026-03-31 was -$4.06.
- Co-Diagnostics, Inc. earnings per share, diluted for the quarter ending 2025-12-31 was $0.26, a 100.52% increase year-over-year.
- Co-Diagnostics, Inc. earnings per share, diluted for the quarter ending 2025-09-30 was -$0.16.
- Co-Diagnostics, Inc. earnings per share, diluted for fiscal 2025 was -$35.25.
- Co-Diagnostics, Inc. earnings per share, diluted for fiscal 2024 was -$37.22.
- Co-Diagnostics, Inc. earnings per share, diluted for fiscal 2023 was -$1.20.
- Co-Diagnostics, Inc. earnings per share, diluted for fiscal 2022 was -$0.45, a 136.59% decline from fiscal 2021.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 6 month as first filed | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month | Earnings Per Share, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.46 10-Q · filed 2026-08-13 | -$4.69 10-Q · filed 2026-08-13 | $1.36 derived: net income ÷ weighted average shares · filed 2026-08-13 | $3.54 derived: net income ÷ weighted average shares · filed 2026-08-13 | |||
| 2026-03-31 | -$4.06 10-Q · filed 2026-05-14 | $0.73 derived: net income ÷ weighted average shares · filed 2026-08-13 | $2.13 derived: net income ÷ weighted average shares · filed 2026-08-13 | $3.44 derived: net income ÷ weighted average shares · filed 2026-08-13 | |||
| 2025-12-31 | $0.26 derived: net income ÷ weighted average shares · filed 2026-07-21 | $1.06 derived: net income ÷ weighted average shares · filed 2026-07-21 | $2.01 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$35.25 10-K · filed 2026-03-31 | |||
| 2025-09-30 | -$0.16 10-Q · filed 2025-11-13 | -$0.70 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.62 10-Q · filed 2025-11-13 | $2.81 derived: net income ÷ weighted average shares · filed 2026-08-13 | |||
| 2025-06-30 | -$7.00 10-Q · filed 2026-08-13 | -$0.23 10-Q · filed 2025-08-14 | -$14.05 10-Q · filed 2026-08-13 | -$0.47 10-Q · filed 2025-08-14 | $0.95 derived: net income ÷ weighted average shares · filed 2026-08-13 | $2.71 derived: net income ÷ weighted average shares · filed 2026-08-13 | |
| 2025-03-31 | -$7.05 10-Q · filed 2026-05-14 | -$0.24 10-Q · filed 2025-05-08 | $0.44 derived: net income ÷ weighted average shares · filed 2026-08-13 | $1.57 derived: net income ÷ weighted average shares · filed 2026-08-13 | $5.86 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||
| 2024-12-31 | $0.13 derived: net income ÷ weighted average shares · filed 2026-07-21 | $0.75 derived: net income ÷ weighted average shares · filed 2026-07-21 | $3.34 derived: net income ÷ weighted average shares · filed 2026-07-21 | -$37.22 10-K · filed 2026-03-31 | -$1.24 10-K · filed 2025-03-27 | ||
| 2024-09-30 | -$0.32 10-Q · filed 2025-11-13 | -$0.57 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$0.88 10-Q · filed 2025-11-13 | -$1.38 derived: net income ÷ weighted average shares · filed 2025-11-13 | |||
| 2024-06-30 | -$0.25 10-Q · filed 2025-08-14 | -$0.56 10-Q · filed 2025-08-14 | -$1.06 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$1.27 derived: net income ÷ weighted average shares · filed 2025-11-13 | |||
| 2024-03-31 | -$0.31 10-Q · filed 2025-05-08 | -$0.81 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$1.01 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$1.32 derived: net income ÷ weighted average shares · filed 2025-11-13 | |||
| 2023-12-31 | -$0.50 derived: net income ÷ weighted average shares · filed 2025-03-27 | -$0.70 derived: net income ÷ weighted average shares · filed 2025-03-27 | -$1.01 derived: net income ÷ weighted average shares · filed 2025-03-27 | -$1.20 10-K · filed 2025-03-27 | |||
| 2023-09-30 | -$0.20 10-Q · filed 2024-11-07 | -$0.51 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$0.70 10-Q · filed 2024-11-07 | -$1.48 derived: net income ÷ weighted average shares · filed 2024-11-07 | |||
| 2023-06-30 | -$0.31 10-Q · filed 2024-08-08 | -$0.50 10-Q · filed 2024-08-08 | -$1.28 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$1.30 derived: net income ÷ weighted average shares · filed 2024-11-07 | |||
| 2023-03-31 | -$0.20 10-Q · filed 2024-05-09 | -$0.98 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$0.99 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$1.06 derived: net income ÷ weighted average shares · filed 2024-11-07 | |||
| 2022-12-31 | -$0.81 derived: net income ÷ weighted average shares · filed 2024-03-14 | -$0.80 derived: net income ÷ weighted average shares · filed 2024-03-14 | -$0.86 derived: net income ÷ weighted average shares · filed 2024-03-14 | -$0.45 10-K · filed 2024-03-14 | |||
| 2022-09-30 | -$0.04 10-Q · filed 2023-11-09 | -$0.13 derived: net income ÷ weighted average shares · filed 2023-11-09 | $0.23 10-Q · filed 2023-11-09 | $0.47 derived: net income ÷ weighted average shares · filed 2023-11-09 | |||
| 2022-06-30 | -$0.08 10-Q · filed 2023-08-10 | $0.27 10-Q · filed 2023-08-10 | $0.51 derived: net income ÷ weighted average shares · filed 2023-11-09 | $0.88 derived: net income ÷ weighted average shares · filed 2023-11-09 | |||
| 2022-03-31 | $0.34 10-Q · filed 2023-05-11 | $0.59 derived: net income ÷ weighted average shares · filed 2023-11-09 | $0.97 derived: net income ÷ weighted average shares · filed 2023-11-09 | $1.30 derived: net income ÷ weighted average shares · filed 2023-11-09 | |||
| 2021-12-31 | $0.25 derived: net income ÷ weighted average shares · filed 2023-03-16 | $0.63 derived: net income ÷ weighted average shares · filed 2023-03-16 | $0.96 derived: net income ÷ weighted average shares · filed 2023-03-16 | $1.23 10-K · filed 2023-03-16 | |||
| 2021-09-30 | $0.38 10-Q · filed 2022-11-10 | $0.71 derived: net income ÷ weighted average shares · filed 2022-11-10 | $0.98 10-Q · filed 2022-11-10 | $1.41 derived: net income ÷ weighted average shares · filed 2022-11-10 | |||
| 2021-06-30 | $0.33 10-Q · filed 2022-08-11 | $0.59 10-Q · filed 2022-08-11 | $1.03 derived: net income ÷ weighted average shares · filed 2022-11-10 | $1.56 derived: net income ÷ weighted average shares · filed 2022-11-10 | |||
| 2021-03-31 | $0.26 10-Q · filed 2022-05-12 | $0.70 derived: net income ÷ weighted average shares · filed 2022-11-10 | $1.23 derived: net income ÷ weighted average shares · filed 2022-11-10 | $1.75 derived: net income ÷ weighted average shares · filed 2022-11-10 | |||
| 2020-12-31 | $0.44 derived: net income ÷ weighted average shares · filed 2022-03-24 | $0.97 derived: net income ÷ weighted average shares · filed 2022-03-24 | $1.49 derived: net income ÷ weighted average shares · filed 2022-03-24 | $1.52 10-K · filed 2022-03-24 | |||
| 2020-09-30 | $0.53 10-Q · filed 2021-11-12 | $1.05 derived: net income ÷ weighted average shares · filed 2021-11-12 | $1.07 10-Q · filed 2021-11-12 | $1.14 derived: net income ÷ weighted average shares · filed 2021-11-12 | |||
| 2020-06-30 | $0.51 10-Q · filed 2021-08-12 | $0.43 10-Q · filed 2020-08-13 | $0.48 10-Q · filed 2021-08-12 | $0.40 10-Q · filed 2020-08-13 | $0.53 derived: net income ÷ weighted average shares · filed 2021-11-12 | $0.49 derived: net income ÷ weighted average shares · filed 2021-11-12 | |
| 2020-03-31 | -$0.05 10-Q · filed 2021-05-13 | -$0.14 derived: net income ÷ weighted average shares · filed 2021-11-12 | -$0.24 derived: net income ÷ weighted average shares · filed 2021-11-12 | -$0.32 derived: net income ÷ weighted average shares · filed 2021-11-12 | |||
| 2019-12-31 | -$0.10 derived: net income ÷ weighted average shares · filed 2021-03-25 | -$0.21 derived: net income ÷ weighted average shares · filed 2021-03-25 | -$0.28 derived: net income ÷ weighted average shares · filed 2021-03-25 | -$0.37 10-K · filed 2021-03-25 | |||
| 2019-09-30 | -$0.10 10-Q · filed 2020-11-16 | -$0.18 derived: net income ÷ weighted average shares · filed 2020-11-16 | -$0.27 10-Q · filed 2020-11-16 | ||||
| 2019-06-30 | -$0.08 10-Q/A · filed 2020-11-03 | -$0.16 10-Q/A · filed 2020-11-03 | |||||
| 2017-09-30 | $1028969.00 10-Q · filed 2017-11-14 | $1028969.00 10-Q · filed 2017-11-14 | |||||
| 2017-06-30 | $3529896.00 10-Q · filed 2017-08-25 | $3529896.00 10-Q · filed 2017-08-25 | |||||
| 2016-09-30 | $4141667.00 10-Q · filed 2017-11-14 | $4141667.00 10-Q · filed 2017-11-14 | |||||
| 2016-06-30 | $1143939.00 10-Q · filed 2017-08-25 | $1143939.00 10-Q · filed 2017-08-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |